151 related articles for article (PubMed ID: 18092743)
1. Optimizing size and copy number for PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarrier uptake by macrophages.
Wan L; Zhang X; Pooyan S; Palombo MS; Leibowitz MJ; Stein S; Sinko PJ
Bioconjug Chem; 2008 Jan; 19(1):28-38. PubMed ID: 18092743
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal macrophage uptake, pharmacokinetics and biodistribution of macrophage-targeted PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarriers for improving HIV drug delivery.
Wan L; Pooyan S; Hu P; Leibowitz MJ; Stein S; Sinko PJ
Pharm Res; 2007 Nov; 24(11):2110-9. PubMed ID: 17701325
[TBL] [Abstract][Full Text] [Related]
3. Conjugates bearing multiple formyl-methionyl peptides display enhanced binding to but not activation of phagocytic cells.
Pooyan S; Qiu B; Chan MM; Fong D; Sinko PJ; Leibowitz MJ; Stein S
Bioconjug Chem; 2002; 13(2):216-23. PubMed ID: 11906258
[TBL] [Abstract][Full Text] [Related]
4. Optimal structural design of mannosylated nanocarriers for macrophage targeting.
Chen P; Zhang X; Jia L; Prud'homme RK; Szekely Z; Sinko PJ
J Control Release; 2014 Nov; 194():341-9. PubMed ID: 25220160
[TBL] [Abstract][Full Text] [Related]
5. Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites.
Qin Y; Li ZW; Yang Y; Yu CM; Gu DD; Deng H; Zhang T; Wang X; Wang AP; Luo WZ
J Drug Target; 2014 Feb; 22(2):165-74. PubMed ID: 24392736
[TBL] [Abstract][Full Text] [Related]
6. The N-formyl methionyl peptide, formyl-methionyl-leucyl phenylalanine (fMLF) increases the lateral diffusion of complement receptor 1 (CR1/CD35) in human neutrophils; a causative role for oxidative metabolites?
Rasmusson BJ; Carpentier JL; Paccaud JP; Magnusson KE
Biosci Rep; 1996 Oct; 16(5):391-404. PubMed ID: 8913529
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of human formyl peptide receptors by calpain inhibitors: homology modeling of receptors and ligand docking simulation.
Fujita H; Kato T; Watanabe N; Takahashi T; Kitagawa S
Arch Biochem Biophys; 2011 Dec; 516(2):121-7. PubMed ID: 22005393
[TBL] [Abstract][Full Text] [Related]
8. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist.
Johansson B; Wymann MP; Holmgren-Peterson K; Magnusson KE
J Cell Biol; 1993 Jun; 121(6):1281-9. PubMed ID: 8509449
[TBL] [Abstract][Full Text] [Related]
9. Conformationally constrained formyl methionyl tripeptides: structure-function study of analogs containing alpha,beta-dehydrophenylalanine and dehydroleucine.
Bharadwaj A; Singh M; Bhandary K; Becker EL; Chauhan VS
Pept Res; 1993; 6(6):298-307. PubMed ID: 8292847
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive detection of passively targeted poly(ethylene glycol) nanocarriers in tumors.
Singh Y; Gao D; Gu Z; Li S; Stein S; Sinko PJ
Mol Pharm; 2012 Jan; 9(1):144-55. PubMed ID: 22077582
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu.
Mills JS; Miettinen HM; Cummings D; Jesaitis AJ
J Biol Chem; 2000 Dec; 275(50):39012-7. PubMed ID: 10960471
[TBL] [Abstract][Full Text] [Related]
12. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
Rotrosen D; Malech HL; Gallin JI
J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
[TBL] [Abstract][Full Text] [Related]
13. The effect of size and polymer architecture of doxorubicin-poly(ethylene) glycol conjugate nanocarriers on breast duct retention, potency and toxicity.
Gu Z; Gao D; Al-Zubaydi F; Li S; Singh Y; Rivera K; Holloway J; Szekely Z; Love S; Sinko PJ
Eur J Pharm Sci; 2018 Aug; 121():118-125. PubMed ID: 29698706
[TBL] [Abstract][Full Text] [Related]
14. Anti-formyl peptide antibodies.
Tanaka F; Jones T; Kubitz D; Lerner RA
Bioorg Med Chem Lett; 2007 Apr; 17(7):1943-5. PubMed ID: 17293112
[TBL] [Abstract][Full Text] [Related]
15. C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2.
Riesselman M; Miettinen HM; Gripentrog JM; Lord CI; Mumey B; Dratz EA; Stie J; Taylor RM; Jesaitis AJ
J Immunol; 2007 Aug; 179(4):2520-31. PubMed ID: 17675514
[TBL] [Abstract][Full Text] [Related]
16. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
17. Unexpected enhancement in biological activity of a GPCR ligand induced by an oligoethylene glycol substituent.
Jiarpinitnun C; Kiessling LL
J Am Chem Soc; 2010 Jul; 132(26):8844-5. PubMed ID: 20536128
[TBL] [Abstract][Full Text] [Related]
18. Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers.
D'Addio SM; Baldassano S; Shi L; Cheung L; Adamson DH; Bruzek M; Anthony JE; Laskin DL; Sinko PJ; Prud'homme RK
J Control Release; 2013 May; 168(1):41-9. PubMed ID: 23419950
[TBL] [Abstract][Full Text] [Related]
19. Regulation of N-formyl-methionyl-leucyl-phenylalanine receptor recycling by surface membrane neutral endopeptidase-mediated degradation of ligand.
Painter RG; Aiken ML
J Leukoc Biol; 1995 Oct; 58(4):468-76. PubMed ID: 7561524
[TBL] [Abstract][Full Text] [Related]
20. Structure, 5'-flanking sequence, and chromosome location of the human N-formyl peptide receptor gene. A single-copy gene comprised of two exons on chromosome 19q.13.3 that yields two distinct transcripts by alternative polyadenylation.
Haviland DL; Borel AC; Fleischer DT; Haviland JC; Wetsel RA
Biochemistry; 1993 Apr; 32(16):4168-74. PubMed ID: 7682842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
